This site is intended for healthcare professionals
Abstract digital waveforms in blue and purple
FDA Drug information

Zolmitriptan

Read time: 1 mins
Marketing start date: 23 Dec 2024
...
 

Summary of product characteristics


Effective Time

20221017

Version

4

Spl Product Data Elements

Zolmitriptan Zolmitriptan ZOLMITRIPTAN ZOLMITRIPTAN ANHYDROUS LACTOSE SILICON DIOXIDE FERRIC OXIDE RED FERRIC OXIDE YELLOW HYPROMELLOSES LACTOSE MONOHYDRATE MAGNESIUM STEARATE CELLULOSE, MICROCRYSTALLINE POLACRILIN POTASSIUM POLYETHYLENE GLYCOL, UNSPECIFIED POLYSORBATE 80 TITANIUM DIOXIDE FD&C BLUE NO. 2 LIGHT YELLOW to YELLOW ROUND 7 Zolmitriptan Zolmitriptan ZOLMITRIPTAN ZOLMITRIPTAN ANHYDROUS LACTOSE SILICON DIOXIDE FERRIC OXIDE RED FERRIC OXIDE YELLOW HYPROMELLOSES LACTOSE MONOHYDRATE MAGNESIUM STEARATE CELLULOSE, MICROCRYSTALLINE POLACRILIN POTASSIUM POLYETHYLENE GLYCOL, UNSPECIFIED POLYSORBATE 80 TITANIUM DIOXIDE LIGHT ORANGE TO ORANGE ROUND 714

Application Number

ANDA203019

Brand Name

Zolmitriptan

Generic Name

Zolmitriptan

Product Ndc

65841-766

Product Type

HUMAN PRESCRIPTION DRUG

Route

ORAL

Package Label Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL NDC 65841-765-86 in unit-dose blister cartons of 6 (1 x 6) unit dose tablets Zolmitriptan Tablets, 2.5 mg Rx only 100 tablets ZYDUS Zolmitriptan tablets, 2.5 mg

Drug section

CME banner

Learning Zones

The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.

Click here to view

Disclaimer

The drug Prescribing Information (PI), including indications, contra-indications, interactions, etc, has been developed using the U.S. Food & Drug Administration (FDA) as a source (www.fda.gov).

Medthority offers the whole library of PI documents from the FDA. Medthority will not be held liable for explicit or implicit errors, or missing data.

Drugs appearing in this section are approved by the FDA. For regions outside of the United States, this content is for informational purposes only and may not be aligned with local regulatory approvals or guidance.